Abstract
Methods for the generation of large numbers of different bispecific antibodies are presented. Cloning strategies are detailed to create repertoires of bispecific diabody molecules with variability on one or both of the antigen binding sites. This diabody format, when combined with the power of phage display technology, allows the generation and analysis of thousands of different bispecific molecules. Selection for binding presumably also selects for more stable diabodies. Phage diabody libraries enable screening or selection of the best combination bispecific molecule with regards to affinity of binding, epitope recognition and pairing before manufacture of the best candidate.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to the full article PDF.
USD 39.95
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Winter, G. and Milstein, C. 1991. Man-made antibodies. Nature 349: 293–299.
Holliger, P. and Winter, G. 1993. Engineering bispecific antibodies. Current Opinions in Biotechnol. 4: 446–449.
Brissinck, J., Demanet, C., Moser, M., Leo, O. and Thielemans, K. 1991. Treatment of mice bearing BCL 1 lymphoma with bispecific antibodies. J. Immunol 147: 4019–4026.
Bagshawe, K.D. 1987. Antibody directed enzymes revive anti-cancer prodrugs concept. Br. J. Cancer 56: 531–532.
Glennie, M.J., Brennand, D.M., Bryden, F, McBride, H.M., Stirpe, F, Worth, A.T., et al. 1988. Bispecific F(ab'γ)2 antibody for the delivery of saporin in the treatment of lymphoma. J. Immunol. 141: 3662–3670.
Milstein, C. and Cuello, A.C. 1983. Hybrid hybridomas and their use in immuno-histochemistry. Nature 305: 537–540.
Karpovsky, B., Titus, J.A., Stephany, D.A. and Segal, D.M. 1984. Production of target-specific effector cells using hetero-crosslinked aggregates containing anti-target cell and anti-Fc-gamma receptor antibodies. J. Exp. Med. 160: 1686–1701.
Holliger, P., Prospero, T., and Winter, G. 1993. “Diabodies”: small bivalent and bispecific antibody fragments. Proc. Natl. Acad. Sci. USA 90: 6444–6448.
Desplancq, D., King, D.J., Lawson, D.G., and Mountain, A. 1994. Multimerization behaviour of single chain Fv variants for the tumour-binding antibody B72.3. Protein Eng. 7: 1027–1033.
Whitlow, M., Filpula, D., Rollence, M.L., Feng, S-L, and Wood, J.R. 1994. Multivalent Fvs: characterization of single-chain Fv oligomers and preparation of a bispecific Fv. Protein Eng. 7: 1017–1026.
Kostelny, S.A., Cole, M.S. and Tso, J.Y. 1992. Formation of a bispecific antibody by the use of leucine zippers. J. Immunol. 148: 1547–1553.
Pack, P. and Pluckthun, A. 1992. Miniantibodies: use of amphipathic helices to produce functional, flexibly linked dimeric FV fragments with high avidity in Escherichia coli . Biochemistry 31: 1579–1584.
Gruber, M., Schodin, B.A., Wilson, E.R. and Kranz, D.M. 1994. Efficient tumor cell lysis mediated by a bispecific single chain antibody expressed in Escherichia coli . J. Immunol. 152: 5368–5374.
Mack, M., Riethmuller, G. and Kufer, P. 1995. A small bispecific antibody construct expressed as a functional single-chain molecule with high tumor cell cytotoxicity. Proc. Natl. Acad. Sci. USA 92: 7021–7025.
McCafferty, J., Griffiths, A.D., Winter, G. and Chiswell, D.J. 1990. Phage antibodies: filamentous phage displaying antibody variable domains. Nature 348: 552–554.
Hoogenboom, H.R., Griffiths, A.D., Johnson, K.S., Chiswell, D., Hudson, P. and Winter, G. 1991. Multi-subunit proteins on the surface of filamentous phage: methodologies for displaying antibody (Fab) heavy and light chains. Nucleic Acids Res. 19: 4133–4137.
Winter, G., Griffiths, A.D., Hawkins, R.E. and Hoogenboom, H.R. 1994. Making anti-bodies by phage display technology. Ann. Rev. Immunol. 12: 433–455.
George, A.J., Titus, J.A., Jost, C.R., Kurucz, I., Perez, P., Andrew, S.M. et al. 1994. Redirection of T cell-mediated cytotoxicity by a recombinant single-chain Fv molecule. J. Immunol. 152: 1802–1811.
Sanna, P.P., De Logo, A., Williamson, R.A., Samson, M.E., Altieri, D.c., Bloom, F.E., et al. 1995. Rapid assay of phage-derived recombinant human Fabs as bispecific anti-bodies. Bio/Technology 13: 1221–1224.
Clackson, T., Hoogenboom, H.R., Griffiths, A.D., and Winter, G. 1991. Making anti-body fragments using phage display libraries. Nature 352: 624–628.
Huston, J.S., Levinson, D., Mudgett-Hunter, M., Tai, M.S., Novotny, J., Margolies, M.N. et al. 1988. Protein engineering of antibody binding sites: recovery of specific activity in an anti-digoxin single-chain Fv analogue produced in Escherichia coli . Proc. Natl. Acad. Sci. USA 85: 5879–5883.
Griffiths, A.D., Williams, S.C., Hartley, O., Tomlinson, I.M., Waterhouse, P., Crosby, W.L. et al. 1994. Isolation of high affinity human antibodies directly from large synthetic repertoires. EMBO J. 13: 3245–3260.
Vaughan, T.J., Williams, A.J., Pritchard, K., Osbourn, U.K., Pope, A.R., Earnshaw, J.C. et al. 1996. Human antibodies with sub-nanomolar affinities isolated from a large non-immunized phage display library. Nature Biotechnology 14: 309–314.
Jönsson, U., Fägerstam, L., Ivarson, B., Lundh, K., Lofas, S., Persson, B., et al. 1991. Real-time biospecific interaction analysis using surface plasmon resonance and a sensor chip technology. Biotechniques 11: 620–627.
Marks, J.D., Griffiths, A.D., Malmquist, M., Malmquist, T., Bye, J.M., and Winter, G. 1992. By-passing immunization: building high affinity human antibodies by chain shuffling. Bio/Technology 10: 779–783.
Marks, J.D., Hoogenboom, H.R., Bonnert, T.R., McCafferty, J., Griffiths, A.D., and Winter, G. 1991. By-passing immunization: Human antibodies from V-gene libraries displayed on phage. J. Mol. Biol. 222: 581–597.
Hoogenboom, H.R. and Winter, G. 1992. By-passing immunisation. Human antibodies from synthetic repertoires of germline VH gene segments rearranged in vitro. J. Mol. Biol. 227: 381–388.
Perisic, O., Webb, P.A., Holliger, P., Winter, G. and Williams, R.L. 1994. Crystal structure of a diabody, a bivalent antibody fragment. Structure 2: 1217–1226.
McCafferty, J. 1994. Selection and rapid purification of murine antibody fragments that bind a transition-state analogue by phage display. Appl. Biochem. Biotechn. 47: 157–173.
Sambrook, J., Fritsch, E.F. and Maniatis, T. 1990. Molecular cloning–a laboratory manual. Cold Spring Harbor Laboratory, New York.
Skerra, A. and Pluckthun, A. 1988. Assembly of a functional immunoglobulin Fv fragment in Escherichia coli . Science 240: 1038–1041.
Mishell, B.B. 1979. pp. 102–103 in Selected methods in cellular immunology. Mishell, B.B. and Shiigi, S.M. (eds.). W.H. Freeman and Company, New York.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
McGuinness, B., Walter, G., FitzGerald, K. et al. Phage diabody repertoires for selection of large numbers of bispecific antibody fragments. Nat Biotechnol 14, 1149–1154 (1996). https://doi.org/10.1038/nbt0996-1149
Received:
Accepted:
Issue date:
DOI: https://doi.org/10.1038/nbt0996-1149
This article is cited by
-
Build-up functionalization of anti-EGFR × anti-CD3 bispecific diabodies by integrating high-affinity mutants and functional molecular formats
Scientific Reports (2020)
-
The use of phage display to generate conformation-sensor recombinant antibodies
Nature Protocols (2012)
-
Selecting and screening recombinant antibody libraries
Nature Biotechnology (2005)
-
Antibody engineering
Biotechnology and Bioprocess Engineering (2002)
-
Somatostatin displayed on filamentous phage as a receptor‐specific agonist
British Journal of Pharmacology (1998)


